Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Roivant Sciences Ltd. Common Shares (ROIV) vs Toronto-Dominion Bank (TD) Price & Performance

Roivant Sciences Ltd. Common SharesTrade
Toronto-Dominion BankTrade

Price performance (Past 24H)

Key statistics

Roivant Sciences Ltd. Common Shares vs Toronto-Dominion Bank — how do they compare? Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B), while Toronto-Dominion Bank trades at $114.14 (market cap $186.61B). The key difference: Toronto-Dominion Bank is far larger — about 7.4× Roivant Sciences Ltd. Common Shares's market cap, and Toronto-Dominion Bank pays a 2.84% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 0 Days and Toronto-Dominion Bank for 84 Days on average.

ROIVTD
Market Cap
$25.09B$186.61B
Volume
5,738,5714,056,663
Sector
HealthFinancials
52-Week High
$41.81$124.80
52-Week Low
$16.04$78.32
Typical Hold Time
0 Days84 Days
Enterprise Value
$21.36B$559.39B
Dividend Yield
—2.84%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Roivant Sciences Ltd. Common Shares

No Aura AI signal available yet.

Toronto-Dominion Bank

TD stock trades at $114.04, down 3.5% today, with a bearish technical signal. Recent earnings have consistently beaten expectations, with Q2 2026 EPS of $1.98 versus $1.74 expected. The company announced a $10 billion share buyback program and is expanding its U.S. branch network. Revenue grew to $61.28 billion in 2025, with a net income margin of 24.88%.

The outlook is mixed: strong profitability and analyst buy ratings support upside, but bearish technicals and volatile cash flows pose risks. The stock's valuation appears reasonable with a P/E of 17.39. Key risks include execution of expansion plans and macroeconomic sensitivity.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ROIV
100% Buy0% Sell
Avg holding period · 0 Days
TD
100% Buy0% Sell
Avg holding period · 84 Days

About Roivant Sciences Ltd. Common Shares

Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.

Read more on ROIV →

About Toronto-Dominion Bank

Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.

Read more on TD →